Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
Thibault Dupont(Assistance Publique – Hôpitaux de Paris), Leandro Cerchietti(Cornell University), Katerina Hatzi(Memorial Sloan Kettering Cancer Center), John P. Leonard(New York University), Peter Martin(Northwestern University), Alka Malik(Cornell University), Wayne Tam(Cornell University), Jayeshkumar Patel(Cornell University), Shao-Ning Yang(Cornell University), Ari Melnick(Cornell University)
Cited by 32
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k